Trial intelligence / Profile preview

Travatan Z vs Xalatan Comfort Comparison

NCT00527592Phase 4Completed

Sponsor
Alcon Inc.
Start
May 2007
Primary completion
Aug 2008
Modality
Prodrugs/Conditional Activator Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Comfort Immediately After Dosing. Started May 2007; status: completed.

02

Drugs

travoprost
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT00527592.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00527592.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call